DETROIT — Starting in March, CDK Global Inc. will give its dealership customers the option to share data contained within their dealership management systems and other CDK software tools with ...
Standard of Care in Hormone Receptor–Positive Metastatic Breast Cancer: Can We Improve the Current Regimens or Develop Better Selection Tools? Antiestrogen therapy remains the targeted therapy par ...
Since joining CDK Global Inc. more than a year ago, CEO Brian Krzanich has emphasized a commitment to improving customer service. The dealership management system giant isn't wavering on that pledge.
TACTIVE-K: Phase 1b/2 study of vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, in combination with PF-07220060, a cyclin-dependent kinase (CDK)4 inhibitor, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results